In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?

Hepatitis C virus (HCV) is responsible for no less than 71 million people chronically infected and is one of the most frequent indications for liver transplantation worldwide. Despite direct-acting antiviral therapies fuel optimism in controlling HCV infections, there are several obstacles regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Echeverría, Natalia, Comas, Victoria, Aldunate, Fabián, Perbolianachis, Paula, Moreno, Pilar, Cristina, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568586/
https://www.ncbi.nlm.nih.gov/pubmed/34786164
http://dx.doi.org/10.4254/wjh.v13.i10.1234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568586/
https://www.ncbi.nlm.nih.gov/pubmed/34786164
http://dx.doi.org/10.4254/wjh.v13.i10.1234

Ejemplares similares